Inventor · disambiguated record
William Blackwell
Also filed as: BLACKWELL III WILLIAM C · BLACKWELL WILLIAM
8 granted patents·8 pending applications·10 citations·filing 2006–2025
80Inventor score
Files withINTARCIA THERAPEUTICS INC7I2O THERAPEUTICS INC4ASTRAZENECA AB3AKTIS ONCOLOGY INC1GLAXO GROUP LTD1
Top patents by PatentIndex Score
16 records- 0190US11840559B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·1 cites·19 claims
- 0289US11739134B2Long acting peptide tyrosine tyrosine (PYY) analogs and methods of useINTARCIA THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·2 cites·20 claims
- 0387US11214607B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2019·Granted Jan 4, 2022·3 cites·20 claims
- 0484US10501517B2Glucagon-receptor selective polypeptides and methods of use thereofINTARCIA THERAPEUTICS INC·Filed 2017·Granted Dec 10, 2019·4 cites·61 claims
- 0580US2024239861A1Glucagon-receptor selective polypeptides and methods of use thereofI2O THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0675US12122816B2Long acting peptide tyrosine tyrosine (PYY) analogs and methods of useINTARCIA THERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·0 cites·25 claims
- 0775US2025084142A1Long acting peptide tyrosine tyrosine (pyy) analogs and methods of useI2O THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0873US2025034225A1Long acting glucagon like polypeptide-1 (glp-1) receptor agonists and methods of useI2O THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0966US12084485B2Long acting glucagon like polypeptide-1 (GLP-1) receptor agonists and methods of useINTARCIA THERAPEUTICS INC·Filed 2021·Granted Sep 10, 2024·0 cites·28 claims
- 1066US12018059B2Human amylin analog polypeptides and methods of useINTARCIA THERAPEUTICS INC·Filed 2019·Granted Jun 25, 2024·0 cites·35 claims
- 1151US2024228572A1Long acting glucagon receptor selective peptides and methods of useI2O THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1248US2011118261A1Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonistsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 1348US2009215841A1D2 Receptor Ligand-078ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1444US2009076064A1CompoundsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1539US2008269275A1Novel Mchr1 Antagonists and Their Use for the Treatment of Mchr1 Mediated Conditions and DisordersASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1638US12427212B2Nectin-4 binding miniproteins, conjugates and uses thereofAKTIS ONCOLOGY INC·Filed 2025·Granted Sep 30, 2025·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when William Blackwell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →